Australia markets closed

Sagimet Biosciences Inc (0O2.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
4.2600-0.3200 (-6.99%)
As of 08:02AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-27,918
-27,876
-30,499
-24,442
-11,370
-
Depreciation & amortisation
-
-
-
-
0
1
Stock-based compensation
4,982
4,990
1,880
1,904
775
-
Change in working capital
106
-978
4,214
-55
75
-
Other working capital
-22,890
-23,766
-24,490
-21,710
-10,416
-
Other non-cash items
141
139
130
134
124
-
Net cash provided by operating activities
-22,890
-23,766
-24,490
-21,710
-10,416
-
Cash flows from investing activities
Purchases of investments
-
-19,620
-41,446
0
-
-
Sales/maturities of investments
15,800
32,200
9,436
0
-
-
Other investing activities
-
-
-
-
-
-27
Net cash used for investing activities
-3,820
12,580
-32,010
0
20
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
-3,364
Common stock issued
195,429
89,679
0
-
-
-
Other financing activities
-4,400
-3,518
-85
-1,254
-
-
Net cash used provided by (used for) financing activities
191,149
86,167
-73
9,739
68,886
-
Net change in cash
164,439
74,981
-56,573
-11,971
58,490
-
Cash at beginning of period
12,338
158
56,731
68,702
10,212
-
Cash at end of period
176,777
75,139
158
56,731
68,702
-
Free cash flow
Operating cash flow
-22,890
-23,766
-24,490
-21,710
-10,416
-
Free cash flow
-22,890
-23,766
-24,490
-21,710
-10,416
-